More DCAT Value Chain Insights

In-depth analysis of the critical issues impacting the full spectrum of the pharmaceutical manufacturing value chain.

DCAT Value Chain Insights

How are the fundamentals for the market for custom synthesis? DCAT Value Chain Insights (VCI) examines the key factors shaping the market and recent activity among fine-chemical producers and contract manufacturers. The collective performance of...
DCAT Value Chain Insights

Strategic sourcing initiatives, such as outsourcing and shared services, are ways in which companies can manage complexity, reduce costs, and achieve operational efficiency. In implementing shared service models, digital technologies are...
DCAT Value Chain Insights

Overall US venture capital funding was up 61% on a value basis in 2014 with life sciences investment up 29%, making 2014 the highest level of life sciences venture capital funding since 2008. The flow of venture capital funding is one important...
DCAT Value Chain Insights

Recent surveys from global and US CEOs provide executive perspective on the prospects for economic growth, company performance, and overarching issues. As we start a new year, how do CEOs see 2015 and the near term? Two separate surveys,...
DCAT Value Chain Insights

A rebound in US economic growth bodes well, but slower growth in China and Europe temper the global macroeconomic outlook. So what should the pharmaceutical industry expect on the macroeconomic front in 2015? A recent analysis by PwC offers five...
DCAT Value Chain Insights

As the pharmaceutical industry begins a new year, what may be the key issues, trends, and events shaping the industry in 2015? DCAT Value Chain Insights (VCI) examines 10 top trends impacting the pharmaceutical manufacturing value chain.  A new...
DCAT Value Chain Insights

What were the key events shaping the global pharmaceutical industry in 2014? DCAT Value Chain Insights (VCI) reviews the highlights from 2014. The end of the year is typically a time of reflection, and in looking back at 2014, what were the key...
DCAT Value Chain Insights

Sun Pharmaceutical Industries Ltd  has moved closer to finalizing its acquisition of Ranbaxy Laboratories. The company have received approval from the Competition Commission of India, subject to certain product divestments and other terms. DCAT...